Refine by
Drug Response Services Available In Canada
16 services found
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Humans are highly organized systems comprised of approximately 3.72×1013 cells of various types, which maintain proper organ function and normal cellular homeostasis. Despite significant and revolutionary discoveries in the field of cell biology, the heterogeneity of cells still requires further investigation. Single-cell RNA sequencing (scRNA-seq) has become the latest method for revealing the ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
Drive biomarker and drug discovery by unlocking novel insights on disease pathophysiology, biomarker expression, and drug response at the tissue and cellular ...
Manufactured by:AAT Bioquest, Inc. based inPleasanton, CALIFORNIA (USA)
Cell based assays offer a biologically relevant substitute to predict the response of a drug on an organism and while initially used mostly for secondary screening, are now progressively being used for primary screens. AAT Bioquest offers a broad spectrum of cell-based assays for cell cytotoxicity, cell proliferation, GPCR and ion channels. Keywords: ...
Manufactured by:Advanced Cell Diagnostics, Inc. based inNewark, CALIFORNIA (USA)
There is growing interest in RNA-based biomarkers and measuring RNA expression holds great promise for stratifying patients based on drug response, drug efficacy and risk of side effects. RNAscope in situ hybridization enables molecular detection in a morphological context. It provides the cellular resolution required to evaluate tissue ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
Manufactured by:CD Formulation based inShirley, NEW YORK (USA)
CD Formulation provides loss-on-drying testing to determine the amount of volatile substances in tablets, capsules or bulk materials. CD Formulation offers a one-stop service for testing the physical and chemical parameters of drugs, providing a rapid response to your testing needs and a credible test ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make informed decisions to advance therapeutic and diagnostic ...
Manufactured by:Intus Biosciences, LLC based inFarmington, CONNECTICUT (USA)
Actionable Results for Industry and Patients. Our cutting-edge Titan-1 platform powers complete ‘sample to answer’ services for pharma, biotech and research partners and clients, delivering response prediction, biomarker identification, and unprecedented insights into the role of the bacterial microbiome for any study or trial. The powerful platform can also support commercial ...
by:OracleBio based inGlasgow, UNITED KINGDOM
Helping you maximise the value of your clinical samples with Quantitative Image Analysis. At OracleBio, we have extensive experience in performing quantitative analysis of tissue samples in clinical research. Our team of expert image analysis scientists performs analysis in a detailed and unbiased manner across digital whole slide tissue images to ensure data is fully representative of the ...
Manufactured by:AnaBios Corporation based inSan Diego, CALIFORNIA (USA)
EX VIVO Human Platforms for Cardiovascular Drug Discovery. Broadly defined, cardiovascular disease is the leading cause of death for men and women across most racial and ethnic groups in the United States with one person dying approximately every 34 seconds1. To drive successful clinical translation of new cardiovascular medicine, AnaBios develops relevant human ex vivo platforms for many ...
by:Excelra based inIselin, NEW JERSEY (USA)
As the volume of biomedical data increases, so does the complexity of drug discovery and development programs. There’s a wealth of opportunity out there but capturing high-quality data and putting it to immediate productive use is often expensive and inefficient. We know that data alone can’t provide insight. You need more than just data. You need ...
Manufactured by:Advanced Brain Monitoring, Inc. based inCarlsbad, CALIFORNIA (USA)
Advanced Brain Monitoring provides full service EEG for clinical trials using the StatX Series wireless EEG systems administered concurrently with a full suite of tasks, including resting state and event-related related protocols. Stat X24 combines rapid application, low patient burden and disposable materials with high quality EEG acquisition easily performed in a clinical or home setting. Our ...
Manufactured by:Firalis Group based inHuningue, FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
by:Biomcare ApS based inAarhus, DENMARK
It is often valuable to study the effect of a product on the gut microbiome or the influence of the microbiome on the effect of a new product, in a controlled setting that eliminates many of the confounding factors that affect the microbiome. Therefore, we offer in vivo tests of new products such as drugs and food ingredients including pre-tox studies, in an integrated workflow with microbiome ...
by:OracleBio based inGlasgow, UNITED KINGDOM
At OracleBio, we have extensive experience in providing pre-clinical services to support clients in the early stages of the drug discovery pipeline. We understand that our clients need their data quickly, so we work hard to ensure a fast turnaround time, with a team of dedicated image analysis scientists and high-powered computing servers for fast image processing. ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Drug affinity responsive target stability is a label-free small molecule probe technique under chemical proteomics first proposed by Lomenick et al. in 2009, which makes it possible to track and identify target proteins whose stability changes after binding with small molecules. To date, Drug affinity responsive target stability ...